Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1;63(2):25.
doi: 10.1167/iovs.63.2.25.

Choroidal Caverns in Stargardt Disease

Affiliations

Choroidal Caverns in Stargardt Disease

Dario Pasquale Mucciolo et al. Invest Ophthalmol Vis Sci. .

Abstract

Purpose: To report choroidal caverns in patients affected by recessive Stargardt disease (STGD1) and to investigate its clinical features.

Methods: Retrospective analysis of STGD1 patients recruited at the Regional Reference Center for Hereditary Retinal Degenerations at the Eye Clinic in Florence from 2012 to 2017. Patients included in the study underwent a complete ophthalmic examination including best-corrected visual acuity, color fundus photography, fundus autofluorescence, optical coherence tomography (OCT) and OCT angiography.

Results: Eighty-six patients (172 eyes) were included in the study. Twenty-three eyes (13.3%) of 21 patients presented choroidal caverns. The total number of detected choroidal caverns was 63. Choroidal caverns were only present in patients with stage III and IV STGD. Interestingly, patients with choroidal caverns presented larger macular atrophy (20.53 ± 16.9 mm2 vs. 18.11 ± 20.39 mm2), worse visual acuity (1.03 ± 0.29 vs. 0.83 ± 0.26), and a thinner choroidal thickness (245.9 ± 88.7 vs. 266.0 ± 110.5 µm).

Conclusions: Choroidal caverns are present only in the advanced stage of STGD1, and a possible degenerative origin of the finding has been hypothesized.

PubMed Disclaimer

Conflict of interest statement

Disclosure: D.P. Mucciolo, None; D. Giorgio, None; M. Lippera, None; V. Dattilo, None; I. Passerini, None; E. Pelo, None; A. Sodi, None; G. Virgili, None; F. Giansanti, None; V. Murro, None

Figures

Figure.
Figure.
(A) Wide-field color fundus photograph of the left eye of a patient affected by STGD1. (B) OCT scan showing choroidal caverns (arrowhead). (C) Fundus autofluorescence imaging characterized by a wide central hypoautofluorescent area surrounded by a speckled FAF response. (D) OCT-A examination does not reveal any flow signal inside the choroidal cavern lesion.

References

    1. Cornish KS, Ho J, Downes S, Scott NW, Bainbridge J, Lois N.. The epidemiology of Stargardt disease in the United Kingdom. Ophthalmol Retina. 2017; 1: 508–513. - PubMed
    1. Allikmets R, Singh N, Sun H, et al. .. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997; 15: 236–246. - PubMed
    1. Passerini I, Sodi A, Giambene B, Mariottini A, Menchini U, Torricelli F.. Novel mutations in of the ABCR gene in Italian patients with Stargardt disease. Eye Lond Engl. 2010; 24: 158–164. - PubMed
    1. Cideciyan AV, Aleman TS, Swider M, et al. .. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004; 13: 525–534. - PubMed
    1. Radu RA, Yuan Q, Hu J, et al. .. Accelerated accumulation of lipofuscin pigments in the RPE of a mouse model for ABCA4-mediated retinal dystrophies following vitamin A supplementation. Invest Ophthalmol Vis Sci. 2008; 49: 3821–3829. - PMC - PubMed

MeSH terms

Substances